PETcision

Founded in 2023, PETcision is a veterinary precision medicine company pioneering non-invasive cancer diagnostics for companion animals. By adapting human-grade liquid biopsy and next-generation sequencing (NGS) technologies, its flagship test screens for up to 20 types of canine cancer through a single blood draw, eliminating the need for anesthesia or invasive biopsies.